Based on the reported immunosuppressive potential of MDSCs in malignant tumors, we analyzed the levels of key immunosuppressive mediators (IDO, ARG1, IL-6, and TGF-β1) in AEG patients. This evidence concerns the gene TGFB1 and cancer.